Clinical Trial Update: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating obeticholic acid in combination with bezafibrate for primary biliary cholangitis has completed, with results not detailed in the upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Bezafibrate (bezafibrate)
• Ocaliva (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Primary Biliary Cholangitis | Phase 2 | Status: COMPLETED